Delivery Order SPE2DB20D3505-SPE2DB24FT6C1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.48 firm-fixed-price delivery order is for the supply of 4,568,061,670 units of the prescription medication Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award....
- This federal contract award, SPE2DB20D3505|SPE2DB25FU2J5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,925.63 firm fixed-price delivery order is for the supply of 4,567,648,830 units of the drug Nateglinide 60 mg Tablet. The contract has a completion date of March 21, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nateglinide 60 mg tablets. The contract has a ceiling value of $4,166.99 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,012.68 firm-fixed-price delivery order is for the supply of 4565699628 Nateglinide 120 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets in quantities of 100 on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $1,573.16 and operates under firm fixed price terms. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the awardee location....
- The Defense Logistics Agency awarded a delivery order valued at $10,181.29 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,518.65 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,694.90 to AmerisourceBergen Drug Corp for 100 tablets of Nateglinide 60 mg, an oral antidiabetic medication. This competitive, non-set-aside delivery order, effective through September 18, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location under firm fixed price terms. The award represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $837 to Amerisourcebergen Drug Corporation for the supply of 30 boxes of 60mg Nateglinide tablets. Performance will take place in Conshohocken, Pennsylvania over a two day period in early August 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its Corporate Office Division location. No major subcontractors or set aside designations were indicated. The...
- This federal contract award, valued at $12,650.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the supply of Repaglinide 1 mg tablets, which are used to treat diabetes. The contract has an Ultimate Completion Date of February 5, 2024 and was awarded on February 2, 2024 under a Firm Fixed Price pricing type. This contract award is not designated with any set-aside...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT6C1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,020.03, is for the delivery of 4,563,324,213 units of the pharmaceutical drug Nateglinide 120 mg tablets in 100-count bottles. The award has an ultimate completion date of January 16, 2024 and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/12/24 |